Neutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA).

Although adenovirus vectors (Ad) which possesses high transduction efficiency are widely used for gene therapy in animal models, clinical use is very limited. One of the main reason is that nearly 80% of human beings possess anti-Ad antibodies. In this study, we tried to modify Ad with methoxypolyethylene glycol (MPEG) activated by succinimidyl propionate, and, the neutralizing antibody evasion ability of PEGylated Ad was evaluated. The results demonstrated that PEG-Ad showed stronger protection ability against anti-Ad neutralizing antibody compared to that with unmodified-Ad. Considering there are many people carrying neutralizing antibody against Ad and readministration of Ad was necessary for treating chronic diseases, this strategy, which was also applicable to other vectors, can be used for developing improved vectors.

[1]  P. Stewart,et al.  A Helper-Independent Adenovirus Vector with E1, E3, and Fiber Deleted: Structure and Infectivity of Fiberless Particles , 1999, Journal of Virology.

[2]  Y. Tsutsumi,et al.  Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector. , 2003, Cancer research.

[3]  B. Trapnell,et al.  Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. , 1994, Gene therapy.

[4]  E. Kominami,et al.  Efficient Mitochondrial Import of Newly Synthesized Ornithine Transcarbamylase (OTC) and Correction of Secondary Metabolic Alterations in spfash Mice following Gene Therapy of OTC Deficiency , 1999, Molecular medicine.

[5]  J. Maizel,et al.  The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. , 1974, Virology.

[6]  M. Hitt,et al.  Human adenovirus vectors for gene transfer into mammalian cells. , 1997, Advances in pharmacology.

[7]  H. Mizuguchi,et al.  Reduction of Natural Adenovirus Tropism to Mouse Liverby Fiber-Shaft Exchange in Combination with both CAR- andαv Integrin-BindingAblation , 2003, Journal of Virology.

[8]  Y. Inada,et al.  Biomedical and biotechnological applications of PEG- and PM-modified proteins. , 1995, Trends in biotechnology.

[9]  B. Trapnell,et al.  Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice , 1993, Nature Genetics.

[10]  M. Bally,et al.  Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids. , 2002, The Journal of pharmacology and experimental therapeutics.

[11]  B. Harvey,et al.  "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. , 1996, Human gene therapy.

[12]  Y. Tsutsumi,et al.  Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency. , 1996, British Journal of Cancer.

[13]  J. Wilson,et al.  Adenoviruses as gene-delivery vehicles. , 1996, The New England journal of medicine.

[14]  Y. Tsutsumi,et al.  Molecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation. , 1996, The Journal of pharmacology and experimental therapeutics.

[15]  M. Chillón,et al.  Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro , 1998, Gene Therapy.

[16]  B. Trapnell,et al.  Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. , 1998, Blood.

[17]  Ronald G. Crystal,et al.  Transfer of Genes to Humans: Early Lessons and Obstacles to Success , 1995, Science.

[18]  C. Wohlfart,et al.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms , 1988, Journal of virology.